MarketAxess Holdings Inc. MKTX
$162.60
+0.00%
at last close
Analyst Consensus
- Consensus Rating
- Hold (0 Buy · 9 Hold · 0 Sell)
- Average Price Target
- $149.00
- Implied Upside
- -8.4%
- Price Target Range
- $128.00 – $170.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | Keefe, Bruyette & WoodsChris Allen |
Downgrades | Outperform → Market perform | $150 → $167 |
| 2026-08-10 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $132 → $167 |
| 2026-07-31 | UBSAlex Kramm |
Downgrades | Buy → Neutral | $200 → $167 |
| 2026-07-15 | Piper SandlerPatrick Moley |
Maintains | Neutral | $175 → $128 |
| 2026-07-10 | Morgan StanleyMichael Cyprys |
Maintains | Equal-weight | $195 → $129 |
| 2026-07-09 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $170 → $132 |
| 2026-07-08 | UBSAlex Kramm |
Maintains | Buy | $215 → $200 |
| 2026-06-30 | Goldman SachsAlexander Blostein |
Maintains | Neutral | $168 → $130 |
| 2026-06-12 | B of A SecuritiesEli Abboud |
Upgrades | Underperform → Neutral | $170 |
| 2026-06-11 | Rothschild & CoSimon Clinch |
Downgrades | Buy → Neutral | $189 → $134 |
| 2026-05-11 | UBSAlex Kramm |
Maintains | Buy | $225 → $215 |
| 2026-05-11 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $189 → $170 |
| 2026-04-08 | Keefe, Bruyette & WoodsChris Allen |
Reinstates | Market perform → Outperform | $195 |
| 2026-03-17 | Argus ResearchKevin Heal |
Downgrades | Buy → Hold | — |
| 2026-02-09 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $182 → $178 |
| 2026-01-15 | Morgan StanleyMichael Cyprys |
Maintains | Equal-weight | $204 → $195 |
| 2026-01-14 | Piper SandlerPatrick Moley |
Maintains | Neutral | $180 → $175 |
| 2026-01-09 | UBSAlex Kramm |
Maintains | Buy | $240 → $225 |
| 2026-01-08 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $188 → $182 |
| 2025-12-22 | Morgan StanleyMichael Cyprys |
Maintains | Equal-weight | $209 → $204 |
| 2025-12-17 | Argus ResearchKevin Heal |
Maintains | Buy | $212 → $205 |
| 2025-11-20 | Morgan StanleyMichael Cyprys |
Downgrades | Overweight → Equal-weight | $247 → $209 |
| 2025-11-10 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $186 → $188 |
| 2025-11-10 | Keefe, Bruyette & WoodsKyle Voigt |
Maintains | Market perform | $194 → $198 |
| 2025-10-08 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $200 → $186 |
| 2025-10-07 | UBSAlex Kramm |
Maintains | Buy | $255 → $240 |
| 2025-10-01 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $274 → $253 |
| 2025-08-25 | Argus ResearchKevin Heal |
Upgrades | Hold → Buy | $212 |
| 2025-08-11 | JefferiesDaniel Fannon |
Maintains | Hold | $217 → $208 |
| 2025-08-07 | UBSAlex Kramm |
Maintains | Buy | $295 → $255 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $162.60
- Market Cap
- $5.72 billion
- 52-Week Range
- $108.75 – $220.42
- Average Volume
- 1.15 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.